Follow
Liwen Wu
Liwen Wu
Takeda Pharmaceutical
Verified email at takeda.com - Homepage
Title
Cited by
Cited by
Year
Psychiatric symptoms in preclinical behavioural-variant frontotemporal dementia in MAPT mutation carriers
G Cheran, H Silverman, M Manoochehri, J Goldman, S Lee, L Wu, ...
Journal of Neurology, Neurosurgery & Psychiatry 89 (5), 449-455, 2018
362018
Cognitive indicators of preclinical behavioral variant frontotemporal dementia in MAPT carriers
G Cheran, L Wu, S Lee, M Manoochehri, S Cines, E Fallon, T Lynch, ...
Journal of the International Neuropsychological Society 25 (2), 184-194, 2019
342019
Management and outcomes of spontaneous pneumomediastinum in children
KA Noorbakhsh, AE Williams, JJW Langham, L Wu, RT Krafty, AD Furtado, ...
Pediatric emergency care 37 (12), e1051-e1056, 2021
292021
E3 ubiquitin ligase Bre1 couples sister chromatid cohesion establishment to DNA replication in Saccharomyces cerevisiae
W Zhang, CHL Yeung, L Wu, KWY Yuen
Elife 6, e28231, 2017
242017
Structural brain changes in pre-clinical FTD MAPT mutation carriers
C Domínguez-Vivero, L Wu, S Lee, M Manoochehri, S Cines, ...
Journal of Alzheimer's Disease 75 (2), 595-606, 2020
142020
Changes in nuclear pore numbers control nuclear import and stress response of mouse hearts
L Han, JD Mich-Basso, Y Li, N Ammanamanchi, J Xu, AP Bargaje, H Liu, ...
Developmental cell 57 (20), 2397-2411. e9, 2022
132022
Using surrogate endpoints in adaptive designs with delayed treatment effect
Q Li, J Lin, M Liu, L Wu, Y Liu
Statistics in Biopharmaceutical Research 14 (4), 661-670, 2022
132022
Adaptive randomization in a two-stage sequential multiple assignment randomized trial
J Wang, L Wu, AS Wahed
Biostatistics 23 (4), 1182-1199, 2022
82022
Interim monitoring in sequential multiple assignment randomized trials
L Wu, J Wang, AS Wahed
Biometrics 79 (1), 368-380, 2023
72023
Incorporating surrogate information for adaptive subgroup enrichment design with sample size re-estimation
L Wu, Q Li, M Liu, J Lin
Statistics in Biopharmaceutical Research 14 (4), 493-504, 2022
72022
Bowel preparation prior to minimally invasive sacrocolpopexy: a randomized controlled trial
JC Sassani, K Kantartzis, L Wu, A Fabio, HM Zyczynski
International urogynecology journal 31, 1305-1313, 2020
62020
Flexible seamless 2-in-1 design with sample size adaptation
R Li, L Wu, R Liu, J Lin
Journal of Biopharmaceutical Statistics, 1-19, 2024
52024
Using surrogate information to improve confirmatory platform trial with sample size re-estimation
C Zhong, Q Li, L Wu, J Lin
Journal of Biopharmaceutical Statistics 32 (4), 547-566, 2022
42022
Opioid e-prescribing trends at discharge in a large pediatric health system
CM Horvat, B Martin, L Wu, A Fabio, PE Empey, F Hagos, S Bigelow, ...
Journal of opioid management 15 (2), 119, 2019
42019
Evolution of phase II oncology trial design: From single arm to master protocol
Z Yu, L Wu, V Bunn, Q Li, J Lin
Therapeutic Innovation & Regulatory Science 57 (4), 823-838, 2023
32023
Use of Surrogate Endpoints in Clinical Development
L Wu, Q Li, J Lin
Case Studies in Innovative Clinical Trials, 191-204, 2023
1*2023
Utility and safety of adenosine challenge for subtle ventricular pre‐excitation in the pediatric population
CW Follansbee, LB Beerman, L Wu, M Bertolet, G Arora
Journal of Cardiovascular Electrophysiology 30 (7), 1036-1041, 2019
12019
An adaptive seamless 2-in-1 design with biomarker-driven subgroup enrichment
L Wu, J Lin
Journal of Biopharmaceutical Statistics, 1-15, 2024
2024
A series of two-sample non-parametric tests for quantile residual life time
Y Liu, L Wu, G Tang, AS Wahed
Lifetime Data Analysis 29 (1), 234-252, 2023
2023
Cardiomyocytes Establish Lower Nuclear Pore Numbers During Maturation, Which Decreases Nuclear Import of Signaling Proteins, Restricts Gene Regulation, and Improves Adverse …
L Han, J Mich-Basso, Y Li, N Ammanamanchi, J Xu, A Bargaje, H Liu, ...
CIRCULATION RESEARCH 131 (12), E174-E174, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20